Sotera Health Co
SHC- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001822479
In the last 90 days, Sotera Health Co insiders filed 0 open-market purchases and 1 sale; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.21B in total; Greenlight Capital is the only superinvestor holding it.
Key figures
- Market capClose on Nov 10, 2026
- $4.65B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $21.2M in total
- 1
- 13F holdersQ2 2026, +23 vs. previous quarter
- 320
- 13F valueReported value at the end of Q2 2026
- $5.21B
- Superinvestors holdingAt the end of Q2 2026
- 1
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.16B
- +5.7% year over year
- Net income, FY2025
- $77.9M
- +75.6% year over year
- Free cash flow, FY2025
- $149.2M
- +230.8% year over year
- Revenue, Q3 FY2026
- $324.9M
- +4.4% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 16.1M
- Shares sold short
- Change
- +1.34M
- +9.1% vs. previous
- Days to cover
- 8.44
- At average daily volume
Superinvestors holding SHC, Q2 2026
Go to the superinvestors tab1 superinvestor reports holding Sotera Health Co on Form 13F. Percentages are the stock's share of each portfolio.
Greenlight Capital
David Einhorn
1.9%
Sotera Health Co's share of the portfolio
- Shares
- 4,135,515
- Value
- $73.4M
Latest insider trades
See all insider tradesOpen-market purchases and sales by Sotera Health Co insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 (view filing)4:24 PM ET | Aug 17 | 2 days | Petras Michael B. Jr.Executive Chairman | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −294.5K | $18.50 | −$5.45M | −42.5%397.9K after | |
| Aug 19, 2026 (view filing)4:24 PM ET | Aug 17 | 2 days | Petras Michael B. Jr.Executive Chairman | SSale | −850.0K | $18.50 | −$15.7M | −17.6%3.97M after | |
| Aug 11, 2026 (view filing)4:24 PM ET | Aug 7 | 4 days | Rutz Michael PPresident of Sterigenics | SSaleCommon Stock, $0.01 par value per share | −150.0K | $18.84 | −$2.83M | −31.0%334.3K after | |
| May 15, 2026 (view filing)4:54 PM ET | May 13 | 2 days | Warburg Pincus & Co. and 7 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −19.1M | $15.17 | −$289.8M | −100.0%0 after | Duplicate filing |
| May 15, 2026 (view filing)4:48 PM ET | May 13 | 2 days | Warburg Pincus & Co. and 9 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −19.1M | $15.17 | −$289.8M | −100.0%0 after | |
| May 15, 2026 (view filing)4:41 PM ET | May 13 | 2 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −12.7M | $15.17 | −$193.2M | −100.0%0 after | |
| Mar 10, 2026 (view filing)7:50 PM ET | Mar 6 | 4 days | Warburg Pincus & Co. and 7 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −15.0M | $15.27 | −$229.1M | −44.0%19.1M after | Duplicate filing |
| Mar 10, 2026 (view filing)7:49 PM ET | Mar 6 | 4 days | Warburg Pincus & Co. and 9 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −15.0M | $15.27 | −$229.1M | −44.0%19.1M after | |
| Mar 10, 2026 (view filing)6:10 PM ET | Mar 6 | 4 days | GTCR Co-Invest XI LP and 4 othersDirector, 10% Owner | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −10.0M | $15.27 | −$152.7M | −44.0%12.7M after | |
| Dec 10, 2025 (view filing) | Dec 8 | 2 days | Petras Michael B. Jr.Chairman & CEO | SSaleCommon Stock, $0.01 par value per share ("Common Stock") | −315.9K | $16.45 | −$5.20M | −36.4%552.8K after |
Top 10 13F holders, Q2 2026
See all 320 holdersThe largest institutional positions in Sotera Health Co at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 27,050,000 | $480.1M | 8.30% | +4,000,000+17.4% | Added |
| Darsana Capital Partners LP | 27,000,000 | $479.3M | 2.15% | +1,000,000+3.8% | Added |
| BlackRock, Inc. | 24,148,424 | $428.6M | 0.01% | +3,298,845+15.8% | Added |
| Sculptor Capital LP | 24,000,000 | $426.0M | 4.41% | +2,282,272+10.5% | Added |
| Sachem Head Capital Management LP | 15,560,000 | $276.2M | 5.73% | +3,915,000+33.6% | Added |
| Vanguard Capital Management LLC | 12,170,699 | $216.0M | 0.00% | +1,435,693+13.4% | Added |
| Vanguard Portfolio Management LLC | 11,946,341 | $212.0M | 0.01% | +1,337,624+12.6% | Added |
| T. Rowe Price Investment Management, Inc. | 10,518,373 | $186.7M | 0.12% | +1,392,752+15.3% | Added |
| AQR Capital Management LLC | 10,734,313 | $186.4M | 0.06% | +4,013,550+59.7% | Added |
| Jupiter Topco LLC | 8,402,106 | $149.1M | 0.06% | +8,402,106 | New |
Holders of 5% or more of SHC
See all 6 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Sotera Health Co.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Sessa Capital IM, L.P. | 13G/A | 9.50%27.1M shares | – | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Darsana Capital Partners LP | 13G/A | 8.80%25.0M shares | – | Sep 13, 20242 filings | Nov 14, 2025 | SEC |
| Sculptor Capital LP | 13G/A | 8.41%24.0M shares | +1.02 ppfrom 7.39% | Sep 11, 20253 filings | Aug 14, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 8.40%23.8M shares | +2.20 ppfrom 6.20% | Oct 17, 20253 filings | Jul 30, 2026 | SEC |
| Sessa Capital (Master), L.P. | 13G | 7.23%20.6M shares | New | Feb 17, 20261 filing | Feb 17, 2026 | SEC |